- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2020–2025 · cooperative agreement · U01
A web-based patient-reported symptom monitoring and self-management portal for adolescent and young adult breast cancer survivors
Michelle J. Naughton · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2028 · research · R25
Advanced Workshop on Research Skills in Oncology
Joseph Andrew Greer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
The role of NCOA4-mediated ferritinophagy in iron homeostasis and ferroptosis
Joseph D Mancias · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · career development · K01
Mesenchymal regulation of fetal intestinal development and adult regeneration
Neil Mccarthy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · career development · K08
Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia
Jacqueline Suen Garcia · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer
Cloud Peter Paweletz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer
Cloud Peter Paweletz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R50
Single cell investigation of co-evolution in cancer cells and host cell immune microenvironment
Shuqiang Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Next Generation Computational Tools for Functional Genomics
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Characterizing the LINE-1 Retrotransposition-Replication Conflict
Kathleen H Burns · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
NMR Fingerprinting: Leveraging optimal control pulse design, tailored isotope labeling, and machine learning to study intractable proteins
Haribabu Arthanari · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · career development · K08
Defining clinically relevant transcriptional networks in gastrointestinal stromal tumor
Matthew Hemming · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R00
De novo design of small-molecule-binding proteins
Nicholas Polizzi · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · grant · PRCRP
CDK4 and Immuno-Targeted Therapies in Liver Tumors Formed in Obesity/Type 2 Diabetes
Pere Puigserver · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2020–2025 · research · R01
Mouse models of Kras-mutant colorectal cancer
Kevin Haigis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · career development · K01
Mesenchymal regulation of fetal intestinal development and adult regeneration
Neil Mccarthy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2024 · career development · K00
Targeting the Nrf2 pathway in cancer
Di Zhang · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
A web-based patient-reported symptom monitoring and self-management portal for adolescent and young adult breast cancer survivors
Michelle J. Naughton · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2024 · grant · PCRP
Molecular and Genetic Determinants of Response to Carboplatin with or without an ATR Inhibitor (M6620) in mCRPC
Atish Choudhury · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2020–2022 · career development · K99
Mechanistic characterization of the anti-inflammatory function of thermogenic fat for the treatment of metabolic disorders
Evanna Louisa Mills · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R37
Molecular mechanisms underlying lineage plasticity in prostate cancer
Himisha Beltran · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · program · P01
Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage
Matthew J. Lang · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
NMR Fingerprinting: Leveraging optimal control pulse design, tailored isotope labeling, and machine learning to study intractable proteins
Haribabu Arthanari · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
The construction and utility of reference pan-genome graphs
Heng Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2022 · research · R21
Tools for DUB Drug Discovery
Sara J Buhrlage · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2024 · fellowship · F32
Identifying Combination Therapies in Ovarian Tumors using High Throughput Dynamic BH3 Profiling
Kelley Mcqueeney · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
William C. Hahn · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2022 · research · R21
Curated prostate cancer data for novel and reproducible prognostic modeling
James Christopher Costello · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · fellowship · F32
Remodeling mitochondrial cristae to rescue bioenergetic defects in mitochondrial disease
Beste Mutlu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · fellowship · F32
Defining IKZF1/IKAROS as an oncogene and therapeutic target in MLL-r AML
Jevon Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2026 · career development · K00
Perturbation based single cell investigation of tumor micro-environment
Chi Zhang · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · career development · K01
Mesenchymal regulation of fetal intestinal development and adult regeneration
Neil Mccarthy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · grant · PCRP
Genomic predictors of clinical outcomes and benefit of (chemo)hormonal therapy in metastatic hormone sensitive prostate cancer
Anis Hamid · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2020–2025 · program · P01
New therapeutic vulnerabilities in breast cancer
Kornelia Polyak · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
The construction and utility of reference pan-genome graphs
Heng Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R37
Liquid biopsy approaches to inform osteosarcoma prognosis and tumor evolution
Brian Crompton · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
The role of NCOA4-mediated ferritinophagy in iron homeostasis and ferroptosis
Joseph D Mancias · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R50
Single cell investigation of co-evolution in cancer cells and host cell immune microenvironment
Shuqiang Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
